DISTRIBUTION AND CHARACTERIZATION OF THE [H-3] GRANISETRON-LABELED 5-HT3 RECEPTOR IN THE HUMAN FOREBRAIN

被引:55
作者
BUFTON, KE
STEWARD, LJ
BARBER, PC
BARNES, NM
机构
[1] UNIV BIRMINGHAM,SCH MED,DEPT PHARMACOL,BIRMINGHAM B15 2TT,ENGLAND
[2] UNIV BIRMINGHAM,SCH MED,DEPT PATHOL,BIRMINGHAM B15 2TT,ENGLAND
关键词
5-HT3; RECEPTOR; HUMAN PUTAMEN; H-3] GRANISETRON; VAGUS NERVE;
D O I
10.1016/0028-3908(93)90027-Z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study has demonstrated the distribution of [H-3]granisetron-labelled 5-HT3, receptors in the human forebrain with relatively high levels of this receptor in homogenates of hippocampus, caudate nucleus, putamen, nucleus accumbens and amygdala. Lower levels of 5-HT, receptors were found in other brain regions and the cervical vagus nerve. Pharmacological characterization of the labelled 5-HT3, receptor in human putamen homogenates identified a relatively low affinity for d-tubocurarine compared to the 5-HT, receptor in NG108-15 neuroblastoma-glioma cell homogenates. In contrast, the affinities of 19 other 5-HT, receptor ligands were not significantly different for the [H-3]granisetron-labelled receptor in these two preparations. Such findings indicate that the human putamen 5-HT3 recep a unique pharmacology which may have significance given the reported clinical potential of compounds active at this receptor when assessed in animal models of disease.
引用
收藏
页码:1325 / 1331
页数:7
相关论文
共 38 条
  • [31] GRANISETRON - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE AS AN ANTIEMETIC
    PLOSKER, GL
    GOA, KL
    [J]. DRUGS, 1991, 42 (05) : 805 - 824
  • [32] THE 5-HT3 RECEPTOR LIGAND, [H-3] BRL 43694, BINDS TO PRESYNAPTIC SITES IN THE NUCLEUS TRACTUS SOLITARIUS OF THE RAT
    PRATT, GD
    BOWERY, NG
    [J]. NEUROPHARMACOLOGY, 1989, 28 (12) : 1367 - 1376
  • [33] LOCALIZATION OF 5-HT3 RECEPTOR-BINDING SITES IN HUMAN DORSAL VAGAL COMPLEX
    REYNOLDS, DJM
    LESLIE, RA
    GRAHAMESMITH, DG
    HARVEY, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 174 (01) : 127 - 130
  • [34] IDENTIFICATION OF SEROTONIN M-RECEPTOR SUBTYPES AND THEIR SPECIFIC BLOCKADE BY A NEW CLASS OF DRUGS
    RICHARDSON, BP
    ENGEL, G
    DONATSCH, P
    STADLER, PA
    [J]. NATURE, 1985, 316 (6024) : 126 - 131
  • [35] CHARACTERISTICS OF 5-HT3 BINDING-SITES IN NG108-15, NCB-20 NEUROBLASTOMA-CELLS AND RAT CEREBRAL-CORTEX USING [H-3] QUIPAZINE AND [H-3] GR65630 BINDING
    SHARIF, NA
    WONG, EHF
    LOURY, DN
    STEFANICH, E
    MICHEL, AD
    EGLEN, RM
    WHITING, RL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (04) : 919 - 925
  • [36] STEWARD JL, 1993, EUR J PHARMACOL, V242, P137
  • [37] 5-HYDROXYTRYPTAMINE3 RECEPTORS IN THE HUMAN-BRAIN - AUTORADIOGRAPHIC VISUALIZATION USING [H-3] ICS 205-930
    WAEBER, C
    HOYER, D
    PALACIOS, JM
    [J]. NEUROSCIENCE, 1989, 31 (02) : 393 - 400
  • [38] LABELING OF 5-HYDROXYTRYPTAMINE3 RECEPTORS WITH A NOVEL 5-HT3 RECEPTOR LIGAND, [H-3] RS-42358-197
    WONG, EHF
    BONHAUS, DW
    WU, I
    STEFANICH, E
    EGLEN, RM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (03) : 921 - 930